Study published in Nature Communications marks a critical step toward the development of a possible cure for human HIV infection Philadelphia, July 02, 2019 (GLOBE NEWSWIRE) — Researchers at the Lewis Katz School...
Biopharma
Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study
First clinical study of a rationally-defined bacterial consortium (VE416) for treating food allergy, will initially be studied in patients with history of peanut allergy Antigen-agnostic approach could potentially be...
